Antagonism of metabotropic glutamate receptor type 5 prevents levodopa‐induced dyskinesia development in a male rat model of Parkinson's disease: Electrophysiological evidence

Documenti analoghi

• Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST‐PD Study
  di: Taku Hatano, et al.
  Pubblicazione: (2024)
• Motor and Cognitive Outcome After Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease Harboring GBA1 Variant
  di: Hikaru Kamo, et al.
  Pubblicazione: (2025)
• Contrasting Effects of Deep Brain Stimulation and Intravenous Levodopa on Local Field Potentials
  di: Hikaru Kamo, et al.
  Pubblicazione: (2026)
• Factors associated with progression of non‐motor symptoms and deterioration in quality of life in Parkinson's disease: Results of J‐FIRST, a 1‐year observational study
  di: Kenichi Kashihara, et al.
  Pubblicazione: (2024)
• Activation of ionotropic and group I metabotropic glutamate receptors stimulates kisspeptin neuron activity in mice
  di: Robin J. Bearss, et al.
  Pubblicazione: (2024)